Disc Medicine IRON Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's financing cash flow?
- Disc Medicine (IRON) reported financing cash flow of $1.7M in Q1 2026.
- How has Disc Medicine's financing cash flow changed year-over-year?
- Disc Medicine's financing cash flow decreased by 99.3% year-over-year, from $244.25M to $1.7M.
- What is the long-term trend for Disc Medicine's financing cash flow?
- Over 3 years (2022 to 2025), Disc Medicine's financing cash flow has grown at a 47.0% compound annual growth rate (CAGR), from $148.98M to $473.41M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.